TransVascular CE-marks two PICVA (percutaneous in-situ coronary venous arterialisation) components:
This article was originally published in Clinica
TransVascular has CE-marked for sale in Europe two components of its investigational system for performing a catheter-based coronary bypass procedure by diverting blood from a diseased artery in the heart to an adjacent vein. The two components of the company's PICVA (percutaneous in-situ coronary venous arterialisation) system are the coronary sinus guiding catheter and introducer and the subselective guiding catheter and introducer. The Menlo Park, California company said that "several" more components would have to be approved before the entire PICVA system would be available for sale.